<DOC>
	<DOC>NCT01850394</DOC>
	<brief_summary>The purpose of this study is to determine 1) the effective dosage of intra-articular tranexamic acid injection for controlling blood loss and blood transfusion requirement in conventional total knee replacement, and 2) whether the blood loss reduction effect depended on the dose of tranexamic acid used.</brief_summary>
	<brief_title>Efficacy of Low-dose Intra-articular Tranexamic Acid in Total Knee Replacement</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>patients diagnosed as primary knee osteoarthritis and underwent unilateral primary cemented conventional total knee replacement no risk of abnormal bleeding tendency or bleeding disorder (normal coagulogram, serum creatinine &lt; 2.0 mg/dL, stop nonsteroidal antiinflammatory drugs and antiplatelet drugs more than 7 days no contraindication for tranexamic acid use (no active intravascular clotting process, no acquired defective colour vision, no subarachnoid hemorrhage, no hypersensitivity to TXA, and no any of history of serious adverse effects, thrombotic disorder and hematuria) incomplete data collection, for example, malfunctioned drain or accidental drain removal.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>